These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6319454)

  • 1. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE; Mahaffey JE; Bartter FC; Neer RM
    J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.
    Broadus AE; Dominguez M; Bartter FC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenous cyclic AMP levels in primary hyperparathyroidism.
    Babka JC; Bower RH; Sode J
    Arch Intern Med; 1976 Oct; 136(10):1140-4. PubMed ID: 184749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Sharp ME; Brown EM; Gardner DG; Downs RW; Attie MF; Stock JL
    J Clin Endocrinol Metab; 1980 Mar; 50(3):546-8. PubMed ID: 6244324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
    Glaser B; Kraiem Z; Rotem M; Gonda M; Bernheim J; Sheinfeld M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):993-7. PubMed ID: 6090499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
    Bill G; Jacquet AF; Burckhardt P
    Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case report: primary hyperparathyroidism--comparison before and after parathyroidectomy by oral calcium tolerance test].
    Sakamoto W; Kawashima H; Nishijima T; Senju M; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1987 Dec; 33(12):2084-9. PubMed ID: 2834926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of calcium intake and the status of intestinal calcium absorption on the diagnostic utility of measurements of 24-hour cyclic adenosine 3',5'-monophosphate excretion.
    Broadus AE; Lang R; Kliger AS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1085-9. PubMed ID: 6262362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary cyclic AMP:creatinine ratio and nephrogenous cyclic AMP as indicators parathyroid functional status.
    Stuart CA; Prochnow PA
    Endocr Res; 1986; 12(1):49-67. PubMed ID: 3009173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans.
    Marcus R; Madvig P; Young G
    J Clin Endocrinol Metab; 1984 Feb; 58(2):223-30. PubMed ID: 6319444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
    Reasner CA; Stone MD; Hosking DJ; Ballah A; Mundy GR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1067-71. PubMed ID: 8408454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral calcium load test: diagnostic and physiologic implications in hyperparathyroidism.
    McHenry CR; Rosen IB; Walfish PG; Pollard A
    Surgery; 1990 Dec; 108(6):1026-31; discussion 1032. PubMed ID: 2174192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency.
    Rubinger D; Friedlaender MM; Silver J; Wald H; Shumart T; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(5):283-7. PubMed ID: 2845240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.